redaporfin

Known as: 5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin, LUZ11 compound 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2018
01220152018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Preclinical evidence depicts the capacity of redaporfin (Redp) to act as potent photosensitizer, causing direct antineoplastic… (More)
Is this relevant?
2018
2018
OBJECTIVE To compare hydrophilic and lipophilic bacteriochlorin photosensitizers in the photodynamic therapy of cancer, and… (More)
Is this relevant?
2016
2016
The therapeutic outcome of photodynamic therapy (PDT) with redaporfin (a fluorinated sulfonamide bacteriochlorin, F2BMet or LUZ11… (More)
Is this relevant?
2016
2016
Photodynamic therapy (PDT) uses light, photosensitizer molecules and oxygen to generate reactive oxygen species (ROS) that kill… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
We assessed the tolerability and safety in rodents of a single intravenous (i.v.) dose of redaporfin, a novel photosensitizer for… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 3
  • table 2
Is this relevant?